Prognostic Performance of Metabolic Indexes in Predicting Onset of Type 1 Diabetes
Open Access
- 31 August 2010
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 33 (12), 2508-2513
- https://doi.org/10.2337/dc10-0802
Abstract
OBJECTIVE In this investigation we evaluated nine metabolic indexes from intravenous glucose tolerance tests (IVGTTs) and oral glucose tolerance tests (OGTTs) in an effort to determine their prognostic performance in predicting the development of type 1 diabetes in those with moderate risk, as defined by familial relation to a type 1 diabetic individual, a positive test for islet cell antibodies and insulin autoantibody, but normal glucose tolerance. RESEARCH DESIGN AND METHODS Subjects (n = 186) who had a projected risk of 25–50% for developing type 1 diabetes within 5 years were followed until clinical diabetes onset or the end of the study as part of the Diabetes Prevention Trial–Type 1. Prognostic performance of the metabolic indexes was determined using receiver operating characteristic (ROC) curve and survival analyses. RESULTS Two-hour glucose from an OGTT most accurately predicted progression to disease compared with all other metabolic indicators with an area under the ROC curve of 0.67 (95% CI 0.59–0.76), closely followed by the ratio of first-phase insulin response (FPIR) to homeostasis model assessment of insulin resistance (HOMA-IR) with an area under the curve value of 0.66. The optimal cutoff value for 2-h glucose (114 mg/dl) maintained sensitivity and specificity values >0.60. The hazard ratio for those with 2-h glucose ≥114 mg/dl compared with those with 2-h glucose <114 mg/dl was 2.96 (1.67–5.22). CONCLUSIONS The ratio of FPIR to HOMA-IR from an IVGTT provided accuracy in predicting the development of type 1 diabetes similar to that of 2-h glucose from an OGTT, which, because of its lower cost, is preferred. The optimal cutoff value determined for 2-h glucose provides additional guidance for clinicians to identify subjects for potential prevention treatments before the onset of impaired glucose tolerance.This publication has 27 references indexed in Scilit:
- Progression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of OnsetDiabetes, 2009
- Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1Diabetes Care, 2008
- Role of Insulin Resistance in Predicting Progression to Type 1 DiabetesDiabetes Care, 2007
- What Is the Best Predictor of Future Type 2 Diabetes?Diabetes Care, 2007
- Increasing the Accuracy of Oral Glucose Tolerance Testing and Extending Its Application to Individuals With Normal Glucose Tolerance for the Prediction of Type 1 DiabetesDiabetes Care, 2007
- Patterns of Metabolic Progression to Type 1 Diabetes in the Diabetes Prevention Trial–Type 1Diabetes Care, 2006
- Models for Predicting Type 1 Diabetes in Siblings of Affected ChildrenDiabetes Care, 2006
- Insulin resistance in type 1 diabetesDiabetes/Metabolism Research and Reviews, 2002
- Risk assessment, prediction and prevention of type 1 diabetesPediatric Diabetes, 2001
- Islet cell antibodies predict insulin-dependent diabetes in United States school age children as powerfully as in unaffected relatives.JCI Insight, 1994